Biotech ETFs can help investors capitalize on health care innovation while avoiding the boom-or-bust nature of individual ...
One of the questions I get more than any other is, “Jonathan, how do you know these stocks will explode when you find them?” The honest answer is, I don’t. Nobody knows ahead of time that a stock is ...
Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...
David Craig’s operating manual for building biotech companies in today’s market is now available in hardcover and as an ...
1mon
‘Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-Covid
Driven by looming patent cliffs, newly buoyant public markets, and Big Pharma's race to beef up their pipelines, dealmaking in 2026 is off to a strong start.
Discover Prague's biotech hub, now viewed as the primary ‘entry gateway’ into the wider Central and Eastern European ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results